PT727996E - Formulacoes de febbendazol - Google Patents

Formulacoes de febbendazol

Info

Publication number
PT727996E
PT727996E PT95901776T PT95901776T PT727996E PT 727996 E PT727996 E PT 727996E PT 95901776 T PT95901776 T PT 95901776T PT 95901776 T PT95901776 T PT 95901776T PT 727996 E PT727996 E PT 727996E
Authority
PT
Portugal
Prior art keywords
febbendazol
formulations
fenbendazole
standing
efficacious
Prior art date
Application number
PT95901776T
Other languages
English (en)
Inventor
Leslie E Kyle
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT727996E publication Critical patent/PT727996E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
PT95901776T 1993-11-10 1994-11-09 Formulacoes de febbendazol PT727996E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/149,877 US5538989A (en) 1993-11-10 1993-11-10 Fenbendazole formulations

Publications (1)

Publication Number Publication Date
PT727996E true PT727996E (pt) 2002-11-29

Family

ID=22532170

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95901776T PT727996E (pt) 1993-11-10 1994-11-09 Formulacoes de febbendazol

Country Status (14)

Country Link
US (1) US5538989A (pt)
EP (1) EP0727996B1 (pt)
JP (1) JP3523260B2 (pt)
KR (1) KR960705563A (pt)
AT (1) ATE221780T1 (pt)
BR (1) BR9408023A (pt)
CA (1) CA2176223C (pt)
DE (1) DE69431162T2 (pt)
DK (1) DK0727996T3 (pt)
ES (1) ES2181763T3 (pt)
MY (1) MY115429A (pt)
PH (1) PH31320A (pt)
PT (1) PT727996E (pt)
WO (1) WO1995013065A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES66993B2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd A process
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
KR100702540B1 (ko) * 1999-09-03 2007-04-04 얀센 파마슈티카 엔.브이. 수 분배 시스템을 통해 표적 동물에 수-불용성 약물을투여하기 위한 수의학적 제제
GB0105358D0 (en) * 2001-03-03 2001-04-18 Fluid Technologies Ltd Absorbent materials
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2005099692A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
EP2037914B1 (en) * 2006-06-14 2013-10-23 Intervet International BV A suspension comprising benzimidazole carbamate and a polysorbate
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
MY174552A (en) * 2010-08-24 2020-04-24 Otsuka Pharma Co Ltd Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
WO2018031935A1 (en) * 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
CN106727304B (zh) * 2017-04-06 2019-09-03 江西博莱大药厂有限公司 一种芬苯达唑混悬剂及其制备方法
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
WO2024026463A1 (en) * 2022-07-28 2024-02-01 Happy Healing Inc. Composition for nasal delivery of an active compound
CN116602964B (zh) * 2023-07-18 2023-09-22 山东国邦药业有限公司 一种芬苯达唑粉及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE684059A (pt) * 1965-07-15 1967-01-13
BE793358A (fr) * 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
US3897559A (en) * 1972-07-06 1975-07-29 Lilly Co Eli Anthelmintic phenylhydrazones
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
IL54474A (en) * 1977-04-12 1982-04-30 Ciba Geigy Ag Benzimidazole derivatives,their preparation and anthelmintic compositions containing them
DE3373276D1 (en) * 1982-03-30 1987-10-08 Hoechst Uk Ltd Anthelmintic preparations

Also Published As

Publication number Publication date
EP0727996B1 (en) 2002-08-07
EP0727996A4 (en) 1996-11-06
CA2176223C (en) 2003-02-11
KR960705563A (ko) 1996-11-08
ES2181763T3 (es) 2003-03-01
JP3523260B2 (ja) 2004-04-26
WO1995013065A1 (en) 1995-05-18
CA2176223A1 (en) 1995-05-18
US5538989A (en) 1996-07-23
BR9408023A (pt) 1996-12-10
MY115429A (en) 2003-06-30
DK0727996T3 (da) 2002-11-18
ATE221780T1 (de) 2002-08-15
JPH09506086A (ja) 1997-06-17
DE69431162T2 (de) 2002-12-12
DE69431162D1 (en) 2002-09-12
PH31320A (en) 1998-07-06
EP0727996A1 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
ES2168414T3 (es) Formulaciones de retinoides en microesferas porosas de irritacion reducida y estabilidad aumentada.
PT727996E (pt) Formulacoes de febbendazol
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
NO970051L (no) Vandige risperidon formuleringer
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ES2060764T3 (es) Composicion cosmetica.
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
GR1001511B (el) Στεροειδείς συν?έσεις.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
ES2062145T3 (es) 1,8-naftiridinas substituidas.
NO941097D0 (no) Hudregenererende kosmetisk preparat
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same